Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
General Internal Medicine
When is it appropriate to recommend a diverting colostomy for treatment of anal cancer or low lying rectal cancer?
Fecal incontinence can be one indication. What are others?
Answer from: Radiation Oncologist at Academic Institution
If there is bowel obstruction/ near obstruction, recto-vaginal or rectovesical fistula formation.
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Academic Institution
I would add inability to pass a colonoscope all the way to the cecum.
Sign In
or
Register
to read more
2701
2705
Related Questions
Which patients, if any, treated according to PROSPECT for an early stage rectal cancer, would you offer surveillance if they achieved cCR after neoadjuvant chemotherapy?
Would you change treatment approach for rectal cancer with an associated intussusception?
Would you recommend adjuvant chemo-RT for an upper rectal pT3N0 (2/24 nodes with positive isolated tumors cells) s/p LAR and FOLFOX?
Would you offer postoperative RT for pT2pN0 rectal cancer with close distal margin (within 2 mm) and only 6 lymph nodes obtained from surgery?
What's your follow up protocol for a near complete response (nCR) in rectal patients considering non-operative management (NOM)?
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
Are you incorporating TTFields into treatment protocols for locally advanced pancreatic cancer based on the PANOVA-3 study?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
Which GI cancer patients do you use oral contrast in staging CT scans?
If a patient with initially borderline resectable pancreatic cancer receives neoadjuvant CHT followed by CRT and is ultimately deemed unresectable, do you consider an RT boost?